• Jaguar Health will hold a special stockholder meeting in San Francisco on Sept. 4, 2026.
• Holders will vote on issuing common stock upon exchange of Series Q Perpetual Preferred Stock held by accredited investors.
• Vote set on repricing investor warrants covering 60,781 common shares to an exercise price of USD 1 per share.
• Proposal includes potential issuance of up to 682,661 common shares tied to the Series O Preferred Stock Dividend upon warrant exercise.
• Meeting also seeks approval to amend the 2014 Stock Incentive Plan, lifting share authorization to 14% on a fully diluted basis as of Sept. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-316119), on July 24, 2026, and is solely responsible for the information contained therein.